---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-028230"
form_type: "8-K"
ticker: "PPCB"
cik: "0001517681"
company_name: "Propanc Biopharma, Inc."
filed_at: "2022-10-12T23:59:59+00:00"
generated_at: "2026-06-23T04:04:43.394257+00:00"
event_type: "debt"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Propanc Biopharma issues $53,750 convertible note to Red Road with 35% discount conversion

## Summary
- Principal $53,750, net proceeds $50,000 after $3,750 fees; maturity Oct 6, 2023; 8% interest.
- Conversion price set at 65% of average lowest 3 trading prices in prior 10 days (35% discount).
- Prepayment premiums range from 110% to 129% of face amount; conversion begins 180 days after issuance.
- Default includes failure to deliver shares, OTC delisting, or financial restatement; default amount 150%.
- Note sold in private placement under Section 4(a)(2) and Regulation D; proceeds for working capital.

## SEC filing metadata
- accession: 0001493152-22-028230
- form_type: 8-K
- ticker: PPCB
- cik: 0001517681
- company_name: Propanc Biopharma, Inc.
- filed_at: 2022-10-12T23:59:59+00:00
- event_type: debt
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1517681/000149315222028230/0001493152-22-028230-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1517681/000149315222028230/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-028230
- JSON: https://secwatch.observer/filing/0001493152-22-028230.json
- Plain text: https://secwatch.observer/filing/0001493152-22-028230.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.